Dunhill Financial’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Dunhill Financial's RVMD Position: Q3 2026 in Review
Dunhill Financial increased its Revolution Medicines (RVMD) stake by 10,150% in Q3 2026, buying an estimated $40.2K and bringing the position to 205 shares worth $444. The position accounts for ﹤0.01% of the portfolio, ranked #1201.
Dunhill Financial first reported a position in RVMD in Q4 2025 and has held it in 4 quarters since. 745 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Dunhill Financial held 205 shares of Revolution Medicines worth $444 as of Q3 2026.
- Dunhill Financial bought 203 Revolution Medicines shares in Q3 2026, an estimated $40.2K.
- Revolution Medicines made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #1201 holding.
- Dunhill Financial first reported a position in Revolution Medicines in Q4 2025 and has held it in 4 quarters since.
- 745 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.